4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-09-014495
Chief Financial Officer acquired 150,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CULPEPPER PETER R · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2009-06-11 | Exercise or conversion : show line 1 in the form | +150,000 | $0.64 | $96,000 | 410,376 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2009-06-11 | Exercise or conversion : show line 2 in the form Stock Options (Right to buy) | −150,000 | $0.64 | 2015-01-07 | 150,000 | 0 | D |
Loading xslF345X03/doc1.xml…